Synaptogenix Inc: Balancing Stock Volatility with Breakthroughs in Neurological Therapies
Synaptogenix Inc. is a biopharmaceutical company committed to addressing neurological challenges, with a focus on innovative treatments for Alzheimer’s disease and other neurodegenerative conditions.
3 minutes to read